18F-FDG Uptake in Neurosarcoid Dural Plaque on PET/CT

Iman Khodarahmi; Roger E. Turbin; Larry P. Frohman; Nasrin Ghesani

doi:10.1097/RLU.0000000000001284

18F-FDG Uptake in Neurosarcoid Dural Plaque on PET/CT

Iman Khodarahmi, Roger E. Turbin, Larry P. Frohman, Nasrin Ghesani

School of Medicine

Research output: Contribution to journal › Article

Abstract

While the imaging modality of choice to diagnose neurosarcoidosis is gadolinium-enhanced MRI, F-FDG PET/CT maybe used to stage the disease or target the optimal biopsy site. Few cases have described intense F-FDG uptake at the sites of active neurosarcoidosis in the midbrain and pituitary gland, cerebellar hemispheres, and temporal lobes. Here, we present a case of neurosarcoidosis whose PET/CT examination demonstrated F-FDG avidity in a dural plaque.

Original language	English (US)
Pages (from-to)	e410-e411
Journal	Clinical nuclear medicine
Volume	41
Issue number	9
DOIs	https://doi.org/10.1097/RLU.0000000000001284
State	Published - Sep 1 2016

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.1097/RLU.0000000000001284

Fingerprint Dive into the research topics of '18F-FDG Uptake in Neurosarcoid Dural Plaque on PET/CT'. Together they form a unique fingerprint.

Cite this

Khodarahmi, I., Turbin, R. E., Frohman, L. P., & Ghesani, N. (2016). 18F-FDG Uptake in Neurosarcoid Dural Plaque on PET/CT. Clinical nuclear medicine, 41(9), e410-e411. https://doi.org/10.1097/RLU.0000000000001284

@article{e9a0b2a76abb41ae8bcd44a40ff400ae,

title = "18F-FDG Uptake in Neurosarcoid Dural Plaque on PET/CT",

abstract = "While the imaging modality of choice to diagnose neurosarcoidosis is gadolinium-enhanced MRI, F-FDG PET/CT maybe used to stage the disease or target the optimal biopsy site. Few cases have described intense F-FDG uptake at the sites of active neurosarcoidosis in the midbrain and pituitary gland, cerebellar hemispheres, and temporal lobes. Here, we present a case of neurosarcoidosis whose PET/CT examination demonstrated F-FDG avidity in a dural plaque. ",

author = "Iman Khodarahmi and Turbin, {Roger E.} and Frohman, {Larry P.} and Nasrin Ghesani",

year = "2016",

month = sep,

day = "1",

doi = "10.1097/RLU.0000000000001284",

language = "English (US)",

volume = "41",

pages = "e410--e411",

journal = "Clinical Nuclear Medicine",

issn = "0363-9762",

publisher = "Lippincott Williams and Wilkins",

number = "9",

}

TY - JOUR

T1 - 18F-FDG Uptake in Neurosarcoid Dural Plaque on PET/CT

AU - Khodarahmi, Iman

AU - Turbin, Roger E.

AU - Frohman, Larry P.

AU - Ghesani, Nasrin

PY - 2016/9/1

Y1 - 2016/9/1

N2 - While the imaging modality of choice to diagnose neurosarcoidosis is gadolinium-enhanced MRI, F-FDG PET/CT maybe used to stage the disease or target the optimal biopsy site. Few cases have described intense F-FDG uptake at the sites of active neurosarcoidosis in the midbrain and pituitary gland, cerebellar hemispheres, and temporal lobes. Here, we present a case of neurosarcoidosis whose PET/CT examination demonstrated F-FDG avidity in a dural plaque.

AB - While the imaging modality of choice to diagnose neurosarcoidosis is gadolinium-enhanced MRI, F-FDG PET/CT maybe used to stage the disease or target the optimal biopsy site. Few cases have described intense F-FDG uptake at the sites of active neurosarcoidosis in the midbrain and pituitary gland, cerebellar hemispheres, and temporal lobes. Here, we present a case of neurosarcoidosis whose PET/CT examination demonstrated F-FDG avidity in a dural plaque.

UR - http://www.scopus.com/inward/record.url?scp=84979650068&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979650068&partnerID=8YFLogxK

U2 - 10.1097/RLU.0000000000001284

DO - 10.1097/RLU.0000000000001284

M3 - Article

C2 - 27454591

AN - SCOPUS:84979650068

VL - 41

SP - e410-e411

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 9

ER -